CD24 and Zika virus infectious disease: Because CD24 is expressed on the surface of a variety of human tumor cells but is not expressed on most differentiated cells, we propose that therapeutic Zika virus infection of individuals with CD24-positive tumors could result in selective tumor cell infection and lysis, offering a potentially novel use for CD24 as a prognostic marker and Zika virus as treatment.